Medicare Enrolled
Dr. Ernest Ribera, MD
Gastroenterology · Burlingame, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ribera from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ribera?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ribera
Dr. Ernest Ribera is a gastroenterology specialist in Burlingame, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ribera performed 1,964 Medicare services across 928 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ribera received a total of $14,744 from 41 pharmaceutical and/or device companies across 679 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ribera is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 10% volume in CA
$14,744 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,964
Medicare services
Top 10% in CA for gastroenterology
928
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~103 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
551 | $44 | $75 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
298 | $56 | $80 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
163 | $33 | $120 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
142 | $74 | $180 |
| Liver stiffness measurement A non-invasive test that uses ultrasound or similar technology to measure the stiffness of liver tissue. This measurement helps assess the degree of liver fibrosis or scarring. |
133 | $30 | $150 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
101 | $214 | $1,100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
99 | $97 | $235 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
90 | $85 | $650 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
78 | $54 | $87 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
65 | $47 | $70 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
64 | $70 | $825 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
54 | $104 | $210 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
22 | $136 | $750 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
22 | $47 | $135 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
19 | $203 | $725 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
18 | $148 | $350 |
| Tissue staining for diagnosis, initial A laboratory test where special stains are applied to tissue slides to help examine the cells and identify specific characteristics. |
16 | $31 | $150 |
| Ultrasound scan of organ tissue for measuring elasticity This procedure uses ultrasound technology to assess the stiffness or elasticity of organ tissues. It helps evaluate tissue characteristics without invasive methods. |
15 | $108 | $250 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
14 | $74 | $575 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,744
Total received (2018-2024)
Avg $2,106/year across 7 years
Top 14% in CA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
679
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,724 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$20 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,130
2023
$2,883
2022
$2,866
2021
$2,224
2020
$1,123
2019
$1,353
2018
$1,165
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$942
Janssen Biotech, Inc.
$558
Lilly USA, LLC
$345
Madrigal Pharmaceuticals
$178
QOL Medical, LLC
$163
PFIZER INC.
$156
Gilead Sciences, Inc.
$122
Phathom Pharmaceuticals, Inc.
$115
Celltrion USA Inc.
$110
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$92
IRONWOOD PHARMACEUTICALS, INC
$83
Takeda Pharmaceuticals U.S.A., Inc.
$66
Fresenius Kabi USA, LLC
$65
Ipsen Biopharmaceuticals, Inc
$53
Merck Sharp & Dohme LLC
$49
AIMMUNE THERAPEUTICS, INC.
$17
Braintree Laboratories, Inc.
$15
Top 3 companies account for 59.0% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$3,317
Janssen Biotech, Inc.
$2,470
Takeda Pharmaceuticals U.S.A., Inc.
$1,297
AbbVie Inc.
$1,188
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$881
QOL Medical, LLC
$587
PFIZER INC.
$584
Gilead Sciences, Inc.
$489
AbbVie, Inc.
$404
Lilly USA, LLC
$371
Braintree Laboratories, Inc.
$273
Ironwood Pharmaceuticals, Inc
$253
Merck Sharp & Dohme LLC
$242
Ferring Pharmaceuticals Inc.
$209
INTERCEPT PHARMACEUTICALS, INC.
$199
Nestle HealthCare Nutrition Inc.
$197
Madrigal Pharmaceuticals
$178
Merck Sharp & Dohme Corporation
$160
Intercept Pharmaceuticals, Inc.
$146
Celltrion USA Inc.
$131
Fresenius Kabi USA, LLC
$122
Celgene Corporation
$122
Phathom Pharmaceuticals, Inc.
$115
Allergan Inc.
$108
IRONWOOD PHARMACEUTICALS, INC
$98
Mauna Kea Technologies, Inc.
$76
NESTLE HEALTHCARE NUTRITION INC.
$66
Daiichi Sankyo Inc.
$58
Ipsen Biopharmaceuticals, Inc
$53
Echosens North America, Inc.
$53
AstraZeneca Pharmaceuticals LP
$47
Prometheus Laboratories Inc.
$45
UCB, Inc.
$37
GENZYME CORPORATION
$31
Romark Laboratories, LC
$26
Janssen Scientific Affairs, LLC
$25
RedHill Biopharma Inc.
$20
Synergy Pharmaceuticals Inc
$20
AIMMUNE THERAPEUTICS, INC.
$17
Regeneron Healthcare Solutions, Inc.
$17
Medtronic, Inc.
$15
Top 3 companies account for 48.0% of all-time payments
Associated products mentioned in payments ›
ANDEXXA · APRISO · Aemcolo · Alinia Tablets 500mg 30 count bottle · Amitiza · Bylvay · CIMZIA · CLENPIQ · CREON · Cimzia · Creon · DIFICID · DUPIXENT · Dexilant · ENTYVIO · Entyvio · FibroScan · GI GENIUS · HUMIRA · Humira · IDACIO · INFLECTRA · INJECTAFER · LINZESS · Linzess · MAVYRET · MOTEGRITY · MOVIPREP · Mavyret · OCALIVA · OMVOH · PLENVU · REBYOTA · REMICADE · RENFLEXIS · RESMETIROM · REZDIFFRA · RINVOQ · SIMPONI ARIA · SKYRIZI · STELARA · SUCRAID · SUFLAVE · SUPREP · SUPREP BOWEL PREP · SUTAB · Sucraid · TREMFYA · TRULANCE · Trulance · UCERIS · VEGZELMA · VIBERZI · VOQUEZNA · Vemlidy · XELJANZ · XIFAXAN · YUFLYMA · ZENPEP · ZEPOSIA · ZYMFENTRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
226
Per 100K population
30.3
County median income
$156,000
Nearest hospital
PENINSULA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ribera is a clinical cardiology specialist, with above-average Medicare volume (top 10% in CA), with low-engagement industry engagement in the top 14% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ribera experienced with chronic care management, additional 20 min/month?
Based on Medicare claims data, Dr. Ribera performed 551 chronic care management, additional 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ribera receive payments from pharmaceutical companies?
Yes. Dr. Ribera received a total of $14,744 from 41 companies across 679 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ribera's costs compare to other gastroenterologists in Burlingame?
Dr. Ribera's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ribera) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Burlingame
Browse gastroenterologists in Burlingame ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in CA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in CA
Which CA gastroenterologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology